Shire Articles
SkyePharma sells Euro Solaraze right to Shire
20 May 2002
Generic success sparks further competition
20 May 2002
Stock Commentary - Europe
13 May 2002
Barr Labs being sued by Organon, Shire
13 May 2002
Shire in-licenses ulcerative colitis therapy
13 May 2002
Shires files Foznol/Fosrenol in USA
6 May 2002
Revenues in 1st-qtr rise 30% at Shire
6 May 2002
Shire US relocates to allow for expansion
29 April 2002
Shire files Xagrid for European approval
8 April 2002
Strakan launches home-grown acne drug Zindaclin in UK
25 March 2002
Shire Pharma director's share purchase
18 March 2002
Stock Commentary - Europe
11 March 2002
D-Pharm gets first milestone on SPD 421
11 March 2002
ADHD : promising new compounds in R&D
25 February 2002
Stock Commentary - Europe
18 February 2002
Barr gets US OK for generic Adderall
18 February 2002
Pfizer sales force "most esteemed by US doctors"
18 February 2002
Novel formulations set to drive ADHD market, study finds
11 February 2002
Barr to launch Dexedrine Spansule generic in Feb?
28 January 2002
Stock Commentary - Europe
28 January 2002
Shire Pharma applies for share listing
28 January 2002
UK parliament
28 January 2002
Shire gets Canadian approval for NeisVac-C.
21 January 2002
Shire redraws deal with HydroMed on histrelin implant
7 January 2002
Shire redraws deal with HydroMed on histrelin implant
28 December 2001
Stock Commentary - Europe
6 December 2001
Blow for Shire as Barr predicts early approval for generic Adderall
29 November 2001
Stock Commentary - Europe
29 November 2001
Stock Commentary - New York
22 November 2001
Shire applies for share listing
21 November 2001
Shire licenses Parkinson's drug from DevCo
20 November 2001
Stock Commentary - Europe
15 November 2001
Shire earnings jump 54% for third quarter
7 November 2001
Shire launches Adderall XR in USA
31 October 2001
Shire initiates Ph II SPD 421 trials
18 October 2001
Stock Commentary - Europe
18 October 2001
Stock Commentary - Europe
11 October 2001
Adherex links up with AstraZeneca
9 October 2001
Datamonitor expresses views on Celebrex vs Vioxx; Novartis ADHD drug
24 September 2001
Wellspring completes Shire's Canadian OTC drug line purchase
5 September 2001
Novartis' Ritadex is "approvable" in USA
23 August 2001
Shire raising $350M through convertible bond
17 August 2001
Stock Commentary - Europe
9 August 2001
Shire nears FDA OK for Adderall XR
8 August 2001
Adherex and Shire terminate alliance
2 August 2001
Stock Commentary - Europe
26 July 2001
US state acts on school use of psychiatric drugs
20 July 2001
UK pharma: return on CEO remuneration mixed
16 July 2001
Superior efficacy for Ziagen/Combivir
11 July 2001
Stock Commentary - Europe
21 June 2001
Reminyl effective in stroke dementia
20 June 2001
Stock Commentary - Europe
7 June 2001
Adderall pricing change
11 May 2001
Shire/BioChem deal gets OK in Canada
10 May 2001
Shire's once-daily ADHD drug effective
10 May 2001
Shire/BioChem merger delayed by Canada
29 March 2001
Japan pharma stock market review - week to March 12
14 March 2001
Canada delays Shire, BioChem merger
14 March 2001
Shire files for Foznol approval in EU
14 March 2001
Shire looks ahead to once-daily Adderall XR results
12 March 2001
Stock Commentary - Europe
8 March 2001
Reminyl approved in USA for Alzheimer's
1 March 2001
Orion in-house drugs now 28% of turnover
23 February 2001
Shire reports revenues up 29% in calendar 2000
14 February 2001
Stock Commentary - Europe
1 February 2001
Earnings increase 41% at BioChem Pharma
1 February 2001
Salix launches Colazal in USA
25 January 2001
The US "biotech century" began with a boom in 2000, says Burrill
25 January 2001
Anagrelide granted orphan status in EU
9 January 2001
Stock Commentary - Europe
4 January 2001
Shire makes progress with sampatrilat
19 December 2000
Stock Commentary - Europe
14 December 2000
Shire Pharmaceuticals and BioChem Pharma announce $4 billion merger
11 December 2000
Stock Commentary - Europe
7 December 2000
Shire licenses Solvay's GI product in Spain
10 November 2000
Overseas sales boost Orion Pharma
10 November 2000
Shire 3rd-qtr pretax profits leap 67%
2 November 2000
First data with Shire's once-daily Adderall
27 October 2000
Janssen launches Reminyl in Europe
26 October 2000
Stock Commentary - Europe
26 October 2000
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
